Immunotherapy drugs continue to gain momentum across a growing range of disease areas with blockbusters such as Merck’s ...

With the recent advances in cell reprogramming, scientists can take a mature human cell — such as a skin cell — and revert it ...

Xvivo Perfusion AB (publ) ( OTCPK:XVIPY) Q3 2025 Earnings Call October 23, 2025 8:00 AM EDT [Operator Instructions] The next question comes from Simon Larsson from Danske Bank.

The Intercept has learned that Amazon sold cloud services to Israeli weapons firms at the height of Israel’s bombardment of ...

It's pretty unusual in the medical system for a patient to be tasked with finding their own cure. But that’s what happened to ...

The Miss USA 2025 pageant will be held in Reno on Friday. This year's contestants include an "American Ninja Warrior" ...

The Business Council is urging the Coalition to negotiate with Labor to avoid the party doing a deal with the Greens — all ...

The Will Stancil Show is a promise of something better. A diamond on a dungheap. Or maybe it’s the opposite. At this stage, ...

Genenta Science S.p.A. stock surged after ANEMOCYTE partnership. Discover temferon's cancer trial updates and what’s next.

Text of the state address by His Excellency, Mr Biodun Oyebanji Governor, Ekiti State, to mark the occasion of the third anniversary celebration of his administration at the Ekiti State House of ...

Objective Interstitial lung disease (ILD) represents the most common and severe organ manifestation observed in patients ...

FDA-approved Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) is available in the United States for the treatment of inflammatory ...